Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
2,600,566
-
Shares change
-
+533,087
-
Total reported value, excl. options
-
$115,305,922
-
Value change
-
+$23,169,696
-
Number of buys
-
55
-
Number of sells
-
-34
-
Price
-
$43.81
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2021
113 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q4 2021.
ISHARES TR - GENOMICS IMMUN (IDNA) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,600,566 shares
.
Largest 10 shareholders include UBS Group AG (308,081 shares), BANK OF AMERICA CORP /DE/ (221,581 shares), MORGAN STANLEY (185,244 shares), Thrivent Financial for Lutherans (168,127 shares), JANE STREET GROUP, LLC (149,160 shares), Wharton Business Group, LLC (138,135 shares), Wealthcare Advisory Partners LLC (130,907 shares), LPL Financial LLC (105,489 shares), CITADEL ADVISORS LLC (83,454 shares), and ROYAL BANK OF CANADA (80,393 shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.